EL LUGAR DE LOS PADRES EN LA ALFABETIZACIÓN MEDIÁTICA DE LOS HIJOS /THE FAMILY ROLE IN THEIR CHILDREN MEDIA EDUCATION Doctora en Periodismo. Miembro de Kids & Com Resumen En esta comunicación pretendemos difundir los resultados de una investigación dirigida a analizar los procesos de mediación de los padres en el uso y consumo televisivo infantil y las estrategias
FOR IMMEDIATE RELEASE Contact: Matthew Alsante
SARCOMA FOUNDATION OF AMERICA HONORS
BEVERLYE HYMAN FEAD WITH COURAGE
Maryland (January 2, 2008) — The Sarcoma Foundation of America, an organization dedicated to increased research funding and advocacy to find new and
better therapies for sarcoma patients, has named Beveryle Hyman Fead as a
recipient of their 2009 Courage Award.
"The Courage Awards are the highest awards presented by the Sarcoma Foundationof America. It is given annually to a sarcoma patients who, through his or her publicor private actions, writings or personal efforts, resulted in the inspiration to othersarcoma patients that they do not have to be physically, emotionally or spirituallydefeated by sarcoma or a diagnosis of sarcoma,” said Mark Thornton, M.D., Ph.D.,President, Sarcoma Foundation of America. “Beveryle Hyman Fead embodies allthat and more.” Beverlye's story of courage and inspiration in her battle with leiomyosarcomamakes her an eminently qualified person to receive this award. In 2002, her doctor predicted that withouttreatment she'd live only two more months. But for Hyman Fead, a debilitating course of chemotherapy andsurgery was as much the enemy as the malignant tumors. Hyman Fead embarked on an experimentaltreatment at UCLA Medical Center. No chemotherapy. No surgery. Instead, she takes the hormoneblockers Femara, by pill daily, and Lupron Depot, by injection every three months, to shrink the tumors.
More than six and a half years later, Beveryle is a vibrant, active woman living with cancer. The tumors arestill there but smaller, thanks to the treatment.
Hyman Fead has penned her story in I Can Do This: Living With Cancer, Tracing a Year of Hope (SBCCWellness Program; $19.99). Her goal is to comfort and energize other cancer patients. "To be the bestpossible patient today, be your own advocate," she says. To that end, she recommends consulting manydoctors - not just one or two.
You can learn more about Beverlye and purchase her amazing story at or join us in person where Beveryle will be honored at our 2009 Gala Monday, April 20, 2009from 6:00 PM to 10:00 PM at Cipriani 42nd Street in New York City. She will also have a book singing atour Ask the Experts Educational Conference: Advances in Sarcoma Treatment and Research, to be held on Sunday, April 19, 2009 from 11:00 AM to 3:30 PM at the New York Helmsley Hotel. Be on the lookout forher new book that she wrote with her granddaughter called Nana What's Cancer. Quick Facts About Sarcoma
Sarcoma is a rare cancer in adults (1 percent of all adult cancers) but rather prevalent in children (about 20
percent of all childhood cancers). At any one time, 50,000 patients and their families are struggling with
sarcoma. Every year, about 10,000 new cases are diagnosed, and about 5,000 people die from sarcoma.
About the Sarcoma Foundation of America
The Sarcoma Foundation of America (SFA), a 501 (c) (3) nonprofit charitable organization, is an advocate
for increased research to find new and better therapies with which to treat patients with sarcoma. SFA raises
its own funds to provide research grants to sarcoma researchers. SFA also interacts with public, private
for-profit, and private non-profit organizations to raise awareness of the treatment needs of sarcoma
patients. For more information, please visit
Reprinted from: Perspectives on new crops and new uses. 1999. J. Janick (ed.), ASHS Press, Alexandria, VA. Immune Stimulants and Antiviral Botanicals: Echinacea and Ginseng Preparations of echinacea and ginseng likely comprise the most popular and commercially successfulcombination of medicinal plant products in North America. Interestingly, the development of Echinacea spe-cies for medi